Mark Richard Dylewski, MD

Naomi Dempsey, M.D., is a board-certified breast medical oncologist at Miami Cancer Institute, part of Baptist Health. She specializes in breast cancer medical oncology.Prior to joining Miami Cancer Institute in 2023, Dr. Dempsey served as a hematologist and breast medical oncologist at the Lynn Cancer Institute where she led the breast cancer research effort. Her work can be found in various publications, including Breast Cancer Research and Treatment and Hematology Oncology Clinics of North America. Before her time at the Lynn Cancer Institute, Dr. Dempsey was chief fellow of hematology and oncology at University of Miami Sylvester Cancer Center.She is a member of the American Society of Clinical Oncology, Alpha Omega Alpha Medical Honors Society and American College of Physicians.Dr. Dempseys approach to care is compassionate and collaborative. She believes in evidence-based methods tailored to her breast cancer patients goals and priorities for their care. She gets to know the patients and their families to understand what is most important to them in their treatment journey. With this information, she creates a treatment plan that will optimize cancer outcomes while accounting for each patients unique needs and values.When she is not treating patients, Dr. Dempsey enjoys spending time with her daughter Keira. She also plays the flute with the Greater Miami Symphonic Band where she serves as the principal piccolo player.

Ian C. Bostock, M.D., MS, FACS, is a board-certified thoracic surgeon at Baptist Health Miami Cancer Institute. He specializes in treating lung and esophageal cancer, mesothelioma, mediastinal and chest wall tumors, and benign esophageal diseases such as reflux, achalasia, and paraesophageal hernias. Dr. Bostock serves as an associate professor of surgery at Florida International University. Prior to joining Baptist Health, he was an assistant professor in the Department of Cardiothoracic Surgery at the Medical University of South Carolina. Dr. Bostock earned his medical degree and a master’s degree in Science and Clinical Investigation at Anáhuac University Medical School in Mexico City, Mexico. He completed a general surgery internship at Brigham and Women’s Hospital, Harvard Medical School and a general surgery residency at Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth. He also completed a cardiothoracic surgery fellowship at MD Anderson Cancer Center, The University of Texas. Dr. Bostock has received several awards for his research in cardiovascular and thoracic surgery. He has published numerous peer-reviewed articles, abstracts and book chapters and has presented at many national academic conferences. He is a fellow of the American College of Surgeons and member of several professional associations. The focus of Dr. Bostock’s care philosophy is patient-centered care and shared-decision making. He believes that each patient should be viewed as an individual and care plans should reflect the patient’s values, goals and motivations. Dr. Bostock is fluent in English and Spanish. When he is not treating patients, he enjoys spending time with his wife and kids and dog, Oli. He also likes to stay active, work out on his Peloton bike and travel to exciting places with his wife.

Rohan Garje, M.D., is a nationally renowned medical oncologist and the chief of genitourinary medical oncology at Miami Cancer Institute. Dr. Garje specializes in the treatment of prostate, kidney, bladder, testicular and penile cancer. Dr Garje has significant expertise in the design of novel investigator-initiated clinical trials and has served as the principal investigator for numerous phase I, II and III clinical trials. He focuses on providing precision oncology care utilizing targeted therapy, hormonal therapy, immunotherapy, radioligand therapy and chemotherapy. Dr. Garje is an internationally published leader in cancer research. He has amassed over 30 publications in prestigious journals, such as Journal of Clinical Oncology and the Journal of Immunotherapy for Cancer. At the Institute, he leads a team of medical oncologists actively involved in clinical research bringing industry-leading treatments to patients with genitourinary cancers. Before joining Miami Cancer Institute in 2022, Dr. Garje served as an associate professor of medicine in hematology and oncology at the University of Iowa/Holden Comprehensive Cancer Center.Dr. Garje is also the chair for the castration-resistant prostate cancer guidelines committee for the American Society of Clinical Oncology. He leads the committee’s work in reviewing research and writing guidelines for prostate cancer treatment. Dr. Garje serves on the editorial board for Current Problems in Cancer and is a reviewer for multiple journals including Journal of Clinical Oncology and Journal of Oncology Practice. Dr. Garje is passionate about providing individual care to each patient because each has a unique journey. He takes time to listen to patients and walks with them throughout their treatment. When he is not treating patients, Dr. Garje enjoys spending time with his family and traveling, always with a camera in hand. He is fluent in English, Hindi, Telugu and Marathi.